Next Article in Journal
Visualization of Biosurfactant Film Flow in a Bacillus subtilis Swarm Colony on an Agar Plate
Next Article in Special Issue
Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
Previous Article in Journal
Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice
Previous Article in Special Issue
Colloidal Stability & Conformational Changes in β-Lactoglobulin: Unfolding to Self-Assembly
Article

Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors

1
Center for Neuro-Medicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, South Korea
2
Biological Chemistry, University of Science and Technology (UST), Daejeon 305-333, South Korea
3
Center for Neuroscience, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, South Korea
4
Department of Neuroscience, University of Science and Technology (UST), Daejeon 305-333, South Korea
*
Authors to whom correspondence should be addressed.
Academic Editor: Salvador Ventura
Int. J. Mol. Sci. 2015, 16(9), 20212-20224; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms160920212
Received: 19 June 2015 / Revised: 12 August 2015 / Accepted: 18 August 2015 / Published: 26 August 2015
(This article belongs to the Collection Protein Folding)
Abnormal phosphorylation of tau has been considered as a key pathogenic mechanism inducing tau aggregation in multiple neurodegenerative disorders, collectively called tauopathies. Recent evidence showed that tau phosphorylation sites are protected with O-linked β-N-acetylglucosamine (O-GlcNAc) in normal brain. In pathological condition, tau is de-glycosylated and becomes a substrate for kinases. Despite the importance of O-GlcNAcylation in tau pathology, O-GlcNAc transferase (OGT), and an enzyme catalyzing O-GlcNAc to tau, has not been carefully investigated in the context of tau aggregation. Here, we investigated intracellular tau aggregation regulated by BZX2, an inhibitor of OGT. Upon the inhibition of OGT, tau phosphorylation increased 2.0-fold at Ser199 and 1.5-fold at Ser396, resulting in increased tau aggregation. Moreover, the BZX2 induced tau aggregation was efficiently reduced by the treatment of Thiamet G, an inhibitor of O-GlcNAcase (OGA). Our results demonstrated the protective role of OGT in tau aggregation and also suggest the counter-regulatory mechanism of OGA and OGT in tau pathology. View Full-Text
Keywords: tau protein; O-GlcNAcylation; O-GlcNAc transferase; O-GlcNAcase; tau phosphorylation; tau aggregation tau protein; O-GlcNAcylation; O-GlcNAc transferase; O-GlcNAcase; tau phosphorylation; tau aggregation
Show Figures

Graphical abstract

MDPI and ACS Style

Lim, S.; Haque, M.M.; Nam, G.; Ryoo, N.; Rhim, H.; Kim, Y.K. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors. Int. J. Mol. Sci. 2015, 16, 20212-20224. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms160920212

AMA Style

Lim S, Haque MM, Nam G, Ryoo N, Rhim H, Kim YK. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors. International Journal of Molecular Sciences. 2015; 16(9):20212-20224. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms160920212

Chicago/Turabian Style

Lim, Sungsu, Md. M. Haque, Ghilsoo Nam, Nayeon Ryoo, Hyewhon Rhim, and Yun K. Kim 2015. "Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors" International Journal of Molecular Sciences 16, no. 9: 20212-20224. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms160920212

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop